{ "company_number": "08735181", "name": "Morgan Immunology Research Limited", "url": "/company/08735181", "status": "active", "is_active": true, "company_type": "ltd", "incorporated_on": "2013-10-16", "dissolved_on": null, "sic_codes": [ { "code": "86210", "description": "General medical practice activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86210" } ], "registered_address": { "id": 1182065, "url": "/address/1182065", "line1": "INGLEWOOD", "line2": "BOVINGDON GREEN", "post_town": "MARLOW", "county": "", "country": "UNITED KINGDOM", "postcode": "SL7 2JH" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08735181", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-10-31", "last_made_up": "2024-10-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/08735181/accounts/2024-10-31", "made_up_date": "2024-10-31", "period_start": "2024-10-31", "period_end": "2024-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "5020.00", "debtors": "61615.00", "cash_bank_in_hand": "43996.00", "current_assets": "105611.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "35326.00", "total_assets_less_current_liabilities": "40346.00", "net_assets_liabilities": "39099.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2025.zip" }, { "url": "/company/08735181/accounts/2023-10-31", "made_up_date": "2023-10-31", "period_start": "2023-10-31", "period_end": "2023-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "2674.00", "debtors": "94141.00", "cash_bank_in_hand": "8266.00", "current_assets": "102407.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "21516.00", "total_assets_less_current_liabilities": "24190.00", "net_assets_liabilities": "23521.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2024.zip" }, { "url": "/company/08735181/accounts/2022-10-31", "made_up_date": "2022-10-31", "period_start": "2022-10-31", "period_end": "2022-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "4041.00", "debtors": "89216.00", "cash_bank_in_hand": "96699.00", "current_assets": "185915.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "127033.00", "total_assets_less_current_liabilities": "131074.00", "net_assets_liabilities": "130306.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2023.zip" }, { "url": "/company/08735181/accounts/2021-10-31", "made_up_date": "2021-10-31", "period_start": "2021-10-31", "period_end": "2021-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "4033.00", "debtors": "104731.00", "cash_bank_in_hand": "182962.00", "current_assets": "287693.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "233673.00", "total_assets_less_current_liabilities": "237706.00", "net_assets_liabilities": "236940.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2022.zip" }, { "url": "/company/08735181/accounts/2020-10-31", "made_up_date": "2020-10-31", "period_start": "2020-10-31", "period_end": "2020-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "4783.00", "debtors": "90415.00", "cash_bank_in_hand": "41114.00", "current_assets": "131529.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "86527.00", "total_assets_less_current_liabilities": "91310.00", "net_assets_liabilities": "90401.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2021.zip" }, { "url": "/company/08735181/accounts/2019-10-31", "made_up_date": "2019-10-31", "period_start": "2019-10-31", "period_end": "2019-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "4241.00", "debtors": "57972.00", "cash_bank_in_hand": "7923.00", "current_assets": "65895.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "26028.00", "total_assets_less_current_liabilities": "30269.00", "net_assets_liabilities": "29463.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2020.zip" }, { "url": "/company/08735181/accounts/2018-10-31", "made_up_date": "2018-10-31", "period_start": "2018-10-31", "period_end": "2018-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "968.00", "debtors": "23253.00", "cash_bank_in_hand": "14150.00", "current_assets": "37403.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "30097.00", "total_assets_less_current_liabilities": "31065.00", "net_assets_liabilities": "30881.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2019.zip" }, { "url": "/company/08735181/accounts/2017-10-31", "made_up_date": "2017-10-31", "period_start": "2017-10-31", "period_end": "2017-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": null, "debtors": "13372.00", "cash_bank_in_hand": "130.00", "current_assets": "13502.00", "creditors_due_within_one_year": "1445.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "12057.00", "total_assets_less_current_liabilities": "12057.00", "net_assets_liabilities": "11920.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "11919.00", "shareholder_funds": "11920.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2018.zip" }, { "url": "/company/08735181/accounts/2016-10-31", "made_up_date": "2016-10-31", "period_start": "2016-10-31", "period_end": "2016-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "684.00", "debtors": "7495.00", "cash_bank_in_hand": "3706.00", "current_assets": "11201.00", "creditors_due_within_one_year": "8075.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3126.00", "total_assets_less_current_liabilities": "3810.00", "net_assets_liabilities": "3673.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "3672.00", "shareholder_funds": "3673.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2017.zip" }, { "url": "/company/08735181/accounts/2015-10-31", "made_up_date": "2015-10-31", "period_start": "2015-10-31", "period_end": "2015-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "1367.00", "debtors": "8280.00", "cash_bank_in_hand": "6785.00", "current_assets": "15065.00", "creditors_due_within_one_year": "9236.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "5829.00", "total_assets_less_current_liabilities": "7196.00", "net_assets_liabilities": "6923.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "6922.00", "shareholder_funds": "6923.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2016.zip" }, { "url": "/company/08735181/accounts/2014-10-31", "made_up_date": "2014-10-31", "period_start": "2014-10-31", "period_end": "2014-10-31", "entity_name": "Morgan Immunology Research Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "2050.00", "debtors": null, "cash_bank_in_hand": "36497.00", "current_assets": "36497.00", "creditors_due_within_one_year": "25744.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "10753.00", "total_assets_less_current_liabilities": "12803.00", "net_assets_liabilities": "12393.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "12392.00", "shareholder_funds": "12393.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2015.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08735181/filing-history" }, "confirmation_statement": { "next_due": "2026-10-30", "last_made_up": "2025-10-16" }, "officers": [], "psc": [ { "name": "Mr Gareth Morgan", "kind": "individual-person-with-significant-control", "person_url": "/person/1624483", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "stream", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-07-31T12:12:06+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }